Background: Very little is known about the long-term neuropsychological outcomes of infants who were treated with pyrimethamine and sulfadiazine for congenital Toxoplasma infection. This study investigated the neurocognitive functioning and behavior of a cohort of treated infants exposed to Toxoplasma gondii in the 1994-1995 outbreak in Victoria, British Columbia. Methods: Ten infants from the original cohort, treated with pyrimethamine and sulfadiazine starting during first year of life and continuing for 12 months, were evaluated at 7 to 8.5 years of age. Neuropsychological evaluations focused on the cognitive, academic, adaptive, and behavioral functioning of these children. Results: The cohort demonstrated generally average neurocognitive abilities and academic achievement. According to parental ratings, the children's executive functions, behavior and adaptive functioning did not differ significantly from the normative population. However, subtle difficulties were seen on more demanding sustained attention and impulse control tasks. Conclusions: These results suggest favorable outcomes in infants who were treated for one year with pyrimethamine and sulfadiazine. Nonetheless, congenital toxoplasmosis might contribute to some difficulties with higher-order cognitive abilities or tasks demanding greater self-monitoring. These difficulties could become more pronounced as higher demands for these abilities and brain areas come online during late childhood and adolescence. These findings highlight the importance of effective treatment and longitudinal follow-up of children with congenital toxoplasmosis.
1996).
Few outcome studies of treated children with congenital Toxoplasma infection have evaluated intellectual abilities. In a series of studies completed by The Chicago Collaborative Treatment Trial, normal intellectual abilities were found in many of the treated children, with intelligence quotient (IQ) scores ranging from 85 to 140 (McAuley et al., 1994) . Lower intellectual scores were noted in some treated children as compared to their uninfected siblings, although repeat testing did not reveal a significant decline in intellectual abilities over time (Roizen et al., 1995) . A follow-up study by the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study found normal intellectual abilities in 77% of treated children with varying degrees of disease involvement at birth. All of the children with no or mild disease had IQ scores greater than 70; however, one child showed a decrease in greater than 15 IQ points over two consecutive evaluations. For children who had moderate to severe neurological disease at birth, 73% scored greater than 70% on intellectual testing and 84% did not show a significant decline in intellectual abilities over time (IQ ≥ 15) . Koppe et al. (1986) found no difference in school performance between children with congenital toxoplasmosis and age-matched peers, although these authors did not differentiate between treated and untreated children. In addition, standardized measures were not used to assess academic achievement in this study.
A questionnaire study at diverse European centers reported parental observations on outcomes of their child at three years of age (Freeman, Salt, Prusa, Malm, Ferret, Buffolano et al., 2005) . There was no evidence of impaired development or behavior in treated children with congenital toxoplasmosis as compared to age-matched controls. However, systematic assessment of functioning at later ages is lacking in children with treated congenital toxoplasmosis.
Little is known about the long-term prognosis of treated infants, nor the impact of treatment on academic achievement, more specific neuropsychological functioning (e.g., attention, memory, language, visuomotor skills, executive functions), and behavior across development. Pediatricians, psychologists and education professionals may need to monitor these children for evidence of relapses and late-onset problems, as congenital disease may continue to have an impact on specific organ function, cognitive development and school performance.
Description of Current Study
The current study was part of a comprehensive research project investigating the long-term outcomes of a unique cohort of children who received similar treatment regimens after being exposed to a unique clonal type of T. gondii in utero during a 1994-1995 waterborne outbreak in Victoria, British Columbia. The purpose of the present study was to extend our knowledge about the long-term outcome of treatment for congenital toxoplasmosis, and to provide a comprehensive evaluation of the neuropsychological functioning, academic achievement and behavior of this unique cohort of treated children. A previous article based on this same sample of children focused on the contextual, familial impact of congenital toxoplasmosis on the parents, and recommendations and insights provided by the families of these children from qualitative interviews were summarized (Roberts, Mortimer, Mish, Kerns, Jagdis, & MacMath, 2005) . To our knowledge, this is the first study to systematically evaluate the neuropsychological functioning of treated children with congenital toxoplasmosis.
Methods

Description of Outbreak
The toxoplasmosis outbreak in the Greater Victoria region was suspected when health professionals noted an increase in serologically positive cases of acute Toxoplasma infection. One hundred acute cases between the ages of 6 and 83 were identified. The municipal drinking water supply was felt to be the source of the organism because of the distribution of cases in the geographic area and the absence of a common identified source in case control studies. At the time, it was the first recorded outbreak to be associated with a municipal drinking water supply (Bowie, King, Werker Isaac-Renton, Bell, Eng, & Marion, 1997 ).
History of Diagnosis and Treatment
Following recognition of the outbreak, a massive screening program for pregnant and postnatal women was undertaken. Screening was offered to women who were pregnant at any time between October 1, 1994 and June 30, 1996 . Based on this screening, 36 of the 3812 screened women tested positive for acute acquired T. gondii infection. A diagnosis of toxoplasmosis was confirmed based on serological findings as described elsewhere (Bowie et al., 1997) . Prenatal treatment was initiated once maternal infection was diagnosed, and continued until the end of pregnancy. Of the infants identified with congenital toxoplasmosis, only 4 mothers were treated prenatally with spiramycin. The mean duration of prenatal treatment was 27.75 days (range, 5 -75 days).
All 36 infants underwent laboratory confirmation of congenital toxoplasmosis. They were tested for IgM, IgG and IgA antibodies to T. gondii, as well as the Dye Test. Twelve infants were identified with congenital toxoplasmosis, and completed a one-year treatment regimen of pyrimethamine, sulfadiazine, and leucovorin according to the recommended treatment protocol for congenital toxoplasmosis (Remington et al., 2006) , with weekly monitoring of blood counts. Mean age at treatment initiation was 86.8 days (range, birth to 274 days). Five children started treatment within the first 3 weeks of life. Specialists in pediatric infectious diseases coordinated evaluation and treatment of the infants.
Participants
The investigated children were recruited from the original cohort of 12 infants infected in the British Columbia toxoplasmosis outbreak (Bowie et al., 1997) . At follow-up in 2001-2002, 10 children (6 males and 4 females) were available for neuropsychological evaluation. All children were between 7 and 8.5 years of age. One family could not be located, and one declined evaluation. Eight families were still residing in the Greater Victoria area, while the others were residing outside the area but were willing to return for testing.
Medical History
Neurological and ophthalmologic sequelae are summarized in Table 1 . During infancy, 3 of the 10 children with congenital toxoplasmosis demonstrated CNS abnormalities. On brain imaging, 2 had intracranial calcifications; one of which was widespread. One case had features of meningoencephalitis on cerebrospinal fluid analysis. However, six children had been diagnosed with chorioretinitis, and all the children were continuing to be followed for further ophthalmologic assessment due to the continued risk for this condition. 
Procedure and Measures
The research protocol was approved by the University of Victoria Human Research Ethics Board and the Vancouver Island Health Authority Child, Youth and Maternal Health Program Research Advisory Committee. Informed written consent and verbal assent were obtained from parents and children, respectively, prior to any testing or interviews. Each family received $50 for participating in the study.
Children were tested in two sessions at the University of Victoria. Intellectual and academic achievement tests were individually administered along with a broad-based battery of neuropsychological function and behavior selected to provide a neuropsychological profile for each child. A full list of the standardized and experimental measures is included in Appendix A. The test battery assessed ten major areas of functioning, including general intelligence, achievement, motor skills, visuomotor skills, language, attention, memory, executive functions, behavior, and adaptive skills. Children who participated in the study did not exhibit any hearing loss or other severe clinical sequelae (e.g., blindness) that would preclude an accurate evaluation.
Parents completed questionnaires regarding their perceptions of their children's executive functions, behavior, and adaptive functioning (Appendix A), as well as participating in a qualitative interview about familial experiences and recommendations. A debriefing of testing results and a brief written report of individual findings were provided to all participating parents.
Additionally, all children underwent a medical examination by a pediatric physician with a specialization in infectious diseases or by their family physician. A follow-up history was obtained at the time of examination.
Data Analysis
Neuropsychological test scores were compared with means of the normative populations on which the tests were standardized (using appropriate normative data for the age and gender of the child) and were converted into standardized scores. This allowed us to quantify differences in the mean test scores of this group of children compared with the normative population using SD from the mean of the latter group. Next, to reduce the number of potential comparisons, tests were grouped by the major cognitive domains, as illustrated in Table 2 . An overall or "grand average" was created by averaging the scores which were all standardized and converted to zscores. These domain averages were then analyzed using an absolute test [via t-test procedure of the Statistical Package for Social Sciences (SPSS)], to assess the likelihood that the group mean differed significantly from the anticipated "average" level and statistically comparing this sample against anticipated scores based on a typically developing normative population (Jeremy, Kim, Nozyce, Nachman, McIntosh, Pelton et al., 2005) . Table 3 summarizes children's performance on measures of attention and executive function, grouped according to subdomains due to the multifactorial nature of these cognitive processes. Subdomains included rote 
Results
As a group, this sample of children with congenital toxoplasmosis exhibited IQ scores that statistically were slightly above an average of 100. Overall, this group of children performed within the average range on measures of verbal (WISC-III Verbal Comprehension Index (VCI): M = 109.6, SD = 9.95) and nonverbal reasoning (WISC-III Perceptual Organization Index (POI): M = 109.4, SD = 11.51). Their scores on measures of academic achievement, motor, visual-motor, language and both verbal and visual memory functions were also within the average range (Figure 1 ). The children with congenital toxoplasmosis also scored within normal limits on the majority of subdomains of attention and executive function. Parental ratings of executive function on the BRIEF were also within age level expectations. However, statistical analyses revealed that on neuropsychological tests of sustained attention and impulse control as a group they scored significantly lower than anticipated (Figure 2) .
Overall, the children's mean scores on the Conner's Parent Rating Scales did not indicate that as a group there were any psychosocial problems (i.e., where T-scores > 65 indicate clinically significant problems). However, 3 of 10 children with congenital toxoplasmosis did demonstrate significant elevations on more than five behavioural scales, and one child showed a significant elevation on the psychosomatic subscale (Table 4) . Overall, the group also demonstrated age-appropriate adaptive functioning.
Discussion
This study explored the neuropsychological profile of treated children exposed to toxoplasmosis in utero. Current results support prior research findings that infants treated with a standardized treatment of pyrimethamine and sulfadiazine for congenital toxoplasmosis have substantially better outcomes than infants with brief or no treatment.
The study provides preliminary evidence of generally average cognitive abilities and academic achievement in treated children with congenital toxoplasmosis. In fact, overall intellectual skills in this group of children were slightly above the average IQ of 100. Nonetheless, on measures of attention and executive function there was some suggestion that congenital toxoplasmosis might contribute to subtle difficulties. Most notably, these children scored significantly lower than would be expected on measures of sustained attention and impulse control. As a group, their median score on sustained attention fell at only the 14 th percentile and on impulse control at the 27 th percentile versus the anticipated group average of 50 th percentile (average). It is important to note that there was considerable variation within the sample of children, with some exhibiting no difficulty on any of the cognitive tasks. However, the only measures on which participants scored in the clinically significant range were on tasks within the attention and executive function domains. 
Limitations
Our study has limitations that must be considered in interpreting the data. A major limitation of the study is the small sample size of only 10 participants. While this is a small sample size, it does represent the majority of the children exposed to T. gondii during the outbreak. Regardless, a larger sample would be optimal for more robust statistical analyses and allow for greater generalization to children with early treatment for exposure to T. gondii.
The representativeness of the sample is also limited. The present cohort was exposed to a unique strain of T. gondii during a community-wide outbreak linked to municipal drinking water. Given the early identification and treatment, these children did not present with severe manifestations of congenital infection. Caution is advised in generalizing the findings to other children with congenital toxoplasmosis. Our results should be viewed as specific to the treatment regimen followed in this study, not all treatment regimens for congenital toxoplasmosis.
Finally, a control group matched for specific characteristics to this sample would have been helpful, such as siblings. While we originally attempted to recruit sibling controls for all participants, there were an insufficient number with siblings. The group was therefore compared test by test to a large normative sample of typically developing children. These limitations need to be kept in mind when interpreting these results.
Conclusions and Future Directions
Notwithstanding the above limitations, the results of this preliminary study suggest age-appropriate cognitive, academic and behavioral functioning in treated children with subclinical congenital toxoplasmosis or minor early clinical signs. Participants presented with subtle clinically and statistically significant reduction in sustained attention and impulse control. Continued follow-up is indicated to confirm these initial results, and to exclude further long-term difficulties in higher order cognitive abilities.
At the time of testing, children in this cohort ranged from 7 to 8.5 years of age. Between the ages of 6 and 12, children undergo considerable development within the domains of executive function, self-regulation and aspects of attention. The subtle differences this group of children exhibits, in comparison to typically developing children's average score, may represent a delay in the maturation of these abilities or could potentially highlight what might be a more enduring difficulty in this area. Thus, continued monitoring and longitudinal multidisciplinary follow-up of this population is warranted.
There is a need to better understand the developmental implications of congenital toxoplasmosis. As brain areas subserving complex attention and executive functions become prominent and important during late child-hood and adolescence when higher levels of self-regulation are anticipated, weaknesses may become more pronounced with age. It is important to determine whether the subtle deficits observed in this population represent a mild "delay" in development of these higher order cognitive abilities or herald a long-term difficulty in this area.
This research project used a blend of quantitative and qualitative methodology to provide a comprehensive understanding of the neurodevelopmental course and familial experiences of congenital toxoplasmosis. A thorough review of the contextual, familial impact of congenital toxoplasmosis on the parents has been previously published (Roberts et al., 2005) . It is important to note, although the children presented with only minor physical and neuropsychological consequences, their parents continued to experience a great deal of concern regarding their child's future health. The lack of information with respect to the long-term effects of congenital toxoplasmosis, specifically in treated children, reinforces their fears of uncertainty about reoccurrence of symptoms in the future. This is consistent with other families with children diagnosed with a chronic illness (Katz, 2002; Dodgson, Garwick, Blozia, Patterson, Bennett, & Blum, 2000) . These findings underscore the importance of effective treatment, family-centered practice, and longitudinal follow-up.
